Title |
Withdrawal syndrome after donepezil cessation in a patient with dementia
|
---|---|
Published in |
Neurological Sciences, January 2012
|
DOI | 10.1007/s10072-012-0938-8 |
Pubmed ID | |
Authors |
Leszek Bidzan, Mariola Bidzan |
Abstract |
We describe a 62-year-old female diagnosed with Alzheimer's disease, who had been treated with donepezil for approximately 1 year. When she developed a low-grade fever and digestive complaints, her family physician interpreted these symptoms as side effects of the drug and ordered donepezil to be discontinued. Not only was there no improvement of the somatic symptoms after discontinuation of donepezil, but there was also a worsening of the dementia symptoms, culminating in delirium. When donepezil was re-prescribed, the delirium resolved and the patient's mental state stabilized. The authors urge great caution in discontinuing treatment with acetylcholinesterase inhibitors such as donepezil. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 6 | 67% |
United Kingdom | 1 | 11% |
Unknown | 2 | 22% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 56% |
Practitioners (doctors, other healthcare professionals) | 2 | 22% |
Scientists | 1 | 11% |
Unknown | 1 | 11% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 51 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 9 | 18% |
Student > Bachelor | 8 | 16% |
Student > Master | 8 | 16% |
Student > Doctoral Student | 4 | 8% |
Professor > Associate Professor | 4 | 8% |
Other | 7 | 14% |
Unknown | 11 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 25% |
Neuroscience | 5 | 10% |
Nursing and Health Professions | 4 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 8% |
Psychology | 4 | 8% |
Other | 7 | 14% |
Unknown | 14 | 27% |